Evidence map›Paper›PMID 40651080›Full record

ArticleDrug and alcohol dependence2025

Acceptability and perceived feasibility of restroom motion sensors for overdose detection and response in public bathrooms: A cross-sectional study of businesses and community organizations.

Joseph G Rosen, Ryan Koch, Rehan Aslam, Gabrielle Riendeau, Maxwell S Krieger, Michelle McKenzie, Susan E Ramsey, Traci C Green, Josiah D Rich, Ju Nyeong Park

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joseph G RosenDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States; Department of Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, United States. Electronic address: joseph_g_rosen@brown.edu.
Ryan KochDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States.
Rehan AslamDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States.
Gabrielle RiendeauDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States.
Maxwell S KriegerDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI, United States.
Michelle McKenzieDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States.
Susan E RamseyDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States; Department of Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School, Brown University, Providence, RI, United States.
Traci C GreenDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI, United States; Department of Emergency Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, United States; Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, United States.
Josiah D RichDepartment of Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, United States; Division of Infectious Diseases, The Miriam Hospital, Providence, RI, United States.
Ju Nyeong ParkDivision of General Internal Medicine, Rhode Island Hospital, Providence, RI, United States; Department of Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Epidemiology, School of Public Health, Brown University, Providence, RI, United States.

Funding

Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI CURT G BECKWITH · 2018 to 2026
$23.4M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
NIGMS NIH HHS P20 GM125507NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

purposeSolitary drug use amplifies fatal overdose risk for people who use drugs. Restroom motion sensors (RMS) are emerging technologies to enhance detection and facilitate rapid response to overdoses in high-traffic public restrooms (where unmonitored drug use is likely to occur), but there has been limited study of employee and staff perspectives on the perceived value and appropriateness of RMS for their workplaces.

methodsFrom November 2022 to April 2024, we identified business, health, and community organizations in opioid overdose hotspots across eight townships in Rhode Island (United States of America), surveying managers and shift supervisors about the acceptability and perceived feasibility of RMS. We analyzed data descriptively, identifying bivariate correlates of RMS acceptability and feasibility, respectively, using Fisher's exact tests of association.

resultsParticipants (median age: 35 years, 53 % cisgender women) across 100 workplaces exhibited low awareness (4 %) but high comfort with RMS being installed (73 %) and confidence (66 %) in implementing RMS in their workplaces in the future. Organizations without staff adequately trained in overdose response were more likely than organizations with trained staff (81 % vs. 64 %, p = 0.055) to endorse confidence in RMS implementation.

conclusionsManagement and shift supervisors in heterogenous occupational contexts endorsed RMS' compatibility and utility in their workplaces, despite low prior awareness of the technology. Efforts to bolster staff competencies in overdose response and equipping workplaces with the necessary tools (i.e., onsite naloxone) to respond appropriately to onsite overdoses will be imperative to successful implementation of RMS in businesses and community organizations.

Indexed as

Drug OverdoseOpiate OverdoseAdultCross-Sectional StudiesFeasibility StudiesFemaleHumansMaleMiddle AgedRhode IslandWorkplaceNaloxoneOpioidsOverdose detection technologiesSolitary drug useUnited States

Identifiers

PMID40651080
PMCPMC12335868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.